JP5810429B2 - 筋タンパク質合成を強化する方法 - Google Patents
筋タンパク質合成を強化する方法 Download PDFInfo
- Publication number
- JP5810429B2 JP5810429B2 JP2012540457A JP2012540457A JP5810429B2 JP 5810429 B2 JP5810429 B2 JP 5810429B2 JP 2012540457 A JP2012540457 A JP 2012540457A JP 2012540457 A JP2012540457 A JP 2012540457A JP 5810429 B2 JP5810429 B2 JP 5810429B2
- Authority
- JP
- Japan
- Prior art keywords
- protein
- carbohydrate
- leucine
- exercise
- training
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000001243 protein synthesis Methods 0.000 title claims description 35
- 230000014616 translation Effects 0.000 title claims description 35
- 102000008934 Muscle Proteins Human genes 0.000 title claims description 20
- 108010074084 Muscle Proteins Proteins 0.000 title claims description 20
- 108090000623 proteins and genes Proteins 0.000 claims description 70
- 102000004169 proteins and genes Human genes 0.000 claims description 70
- 238000012549 training Methods 0.000 claims description 44
- 239000000203 mixture Substances 0.000 claims description 32
- 150000001720 carbohydrates Chemical class 0.000 claims description 26
- 235000020776 essential amino acid Nutrition 0.000 claims description 24
- 239000003797 essential amino acid Substances 0.000 claims description 24
- 235000016709 nutrition Nutrition 0.000 claims description 20
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 19
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 19
- 230000003252 repetitive effect Effects 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 12
- 230000035764 nutrition Effects 0.000 claims description 9
- 230000002708 enhancing effect Effects 0.000 claims description 4
- 230000037406 food intake Effects 0.000 claims description 3
- 230000013663 muscle adaptation Effects 0.000 claims description 3
- 235000018102 proteins Nutrition 0.000 description 53
- 230000006978 adaptation Effects 0.000 description 16
- 239000000047 product Substances 0.000 description 15
- 235000014633 carbohydrates Nutrition 0.000 description 13
- 229940068196 placebo Drugs 0.000 description 13
- 239000000902 placebo Substances 0.000 description 13
- 238000011084 recovery Methods 0.000 description 13
- 150000005693 branched-chain amino acids Chemical class 0.000 description 12
- 239000003925 fat Substances 0.000 description 11
- 235000019197 fats Nutrition 0.000 description 11
- 210000003205 muscle Anatomy 0.000 description 11
- 235000015097 nutrients Nutrition 0.000 description 11
- 229940024606 amino acid Drugs 0.000 description 10
- 150000001413 amino acids Chemical class 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 229920002527 Glycogen Polymers 0.000 description 7
- 229940096919 glycogen Drugs 0.000 description 7
- 230000026731 phosphorylation Effects 0.000 description 6
- 238000006366 phosphorylation reaction Methods 0.000 description 6
- 230000011664 signaling Effects 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 230000001351 cycling effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000006286 nutrient intake Nutrition 0.000 description 4
- 108010046377 Whey Proteins Proteins 0.000 description 3
- 102000007544 Whey Proteins Human genes 0.000 description 3
- 230000001195 anabolic effect Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 210000003470 mitochondria Anatomy 0.000 description 3
- 235000021075 protein intake Nutrition 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 108010013238 70-kDa Ribosomal Protein S6 Kinases Proteins 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 108010011756 Milk Proteins Proteins 0.000 description 2
- 102000014171 Milk Proteins Human genes 0.000 description 2
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 235000021074 carbohydrate intake Nutrition 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 2
- 230000002414 glycolytic effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000021239 milk protein Nutrition 0.000 description 2
- 230000002438 mitochondrial effect Effects 0.000 description 2
- 230000037257 muscle growth Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 229940001941 soy protein Drugs 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 235000021119 whey protein Nutrition 0.000 description 2
- OCUSNPIJIZCRSZ-ZTZWCFDHSA-N (2s)-2-amino-3-methylbutanoic acid;(2s)-2-amino-4-methylpentanoic acid;(2s,3s)-2-amino-3-methylpentanoic acid Chemical compound CC(C)[C@H](N)C(O)=O.CC[C@H](C)[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O OCUSNPIJIZCRSZ-ZTZWCFDHSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 102100022466 Eukaryotic translation initiation factor 4E-binding protein 1 Human genes 0.000 description 1
- 108050000946 Eukaryotic translation initiation factor 4E-binding protein 1 Proteins 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 108010070551 Meat Proteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000009793 Milk Hypersensitivity Diseases 0.000 description 1
- 201000010859 Milk allergy Diseases 0.000 description 1
- 102000000562 Monocarboxylic Acid Transporters Human genes 0.000 description 1
- 108010041817 Monocarboxylic Acid Transporters Proteins 0.000 description 1
- 206010028311 Muscle hypertrophy Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 108010033929 calcium caseinate Proteins 0.000 description 1
- 239000000828 canola oil Substances 0.000 description 1
- 235000019519 canola oil Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000021196 dietary intervention Nutrition 0.000 description 1
- 235000020979 dietary recommendations Nutrition 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 210000000600 glycolytic muscle fiber Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 238000001964 muscle biopsy Methods 0.000 description 1
- 230000012042 muscle hypertrophy Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000003365 myofibril Anatomy 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 235000021400 peanut butter Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229950007002 phosphocreatine Drugs 0.000 description 1
- 230000036314 physical performance Effects 0.000 description 1
- 230000010254 physiological adaptation Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000013138 pruning Methods 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 108091006024 signal transducing proteins Proteins 0.000 description 1
- 102000034285 signal transducing proteins Human genes 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 230000037078 sports performance Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pediatric Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09177423.2 | 2009-11-29 | ||
| EP09177423.2A EP2327316B1 (en) | 2009-11-29 | 2009-11-29 | Method of enhancing muscle protein synthesis |
| PCT/EP2010/068439 WO2011064373A1 (en) | 2009-11-29 | 2010-11-29 | Method of enhancing muscle protein synthesis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013511970A JP2013511970A (ja) | 2013-04-11 |
| JP5810429B2 true JP5810429B2 (ja) | 2015-11-11 |
Family
ID=42135915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012540457A Expired - Fee Related JP5810429B2 (ja) | 2009-11-29 | 2010-11-29 | 筋タンパク質合成を強化する方法 |
Country Status (13)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10016472B2 (en) | 2012-06-11 | 2018-07-10 | William J. Kraemer | Methods of mitigating the negative effects of resistance exercise |
| US20150150898A1 (en) * | 2012-06-11 | 2015-06-04 | Nu Science Laboratories, Inc. | Nutritional products and methods of improving exercise performance and reducing exercise induced impairment of immune function |
| HK1214739A1 (zh) * | 2012-11-20 | 2016-09-30 | Axcella Health Inc. | 工程化的分泌蛋白质和方法 |
| US9820504B2 (en) | 2013-03-08 | 2017-11-21 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
| WO2014138304A1 (en) | 2013-03-08 | 2014-09-12 | Axiom Foods, Inc., | Rice protein supplements |
| WO2014155249A1 (en) * | 2013-03-26 | 2014-10-02 | Nestec S.A. | Methods for enhancing muscle protein synthesis following concurrent training |
| US10271570B2 (en) | 2013-08-15 | 2019-04-30 | Nu Science Laboratories, Inc. | Compositions for and methods of diet supplementation |
| WO2015040533A1 (en) * | 2013-09-19 | 2015-03-26 | Premier Nutrition Corporation | Methods for enhancing muscle protein synthesis during energy deficit |
| PL238958B1 (pl) * | 2016-06-29 | 2021-10-25 | Olimp Laboratories Spolka Z Ograniczona Odpowiedzialnoscia | Kompozycja aminokwasowa do stosowania przed wysiłkiem fizycznym |
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| CN110868870A (zh) | 2017-05-12 | 2020-03-06 | 艾斯姆食品公司 | 大米产物及制备它们的系统和方法 |
| CN111295187A (zh) | 2017-08-14 | 2020-06-16 | 胺细拉健康公司 | 用于治疗肝脏疾病的氨基酸组合物 |
| AR115585A1 (es) | 2018-06-20 | 2021-02-03 | Axcella Health Inc | Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1075713C (zh) * | 1996-05-23 | 2001-12-05 | 大塚制药株式会社 | 降低身体脂肪含量和改善身体组成的食物组合物及其方法 |
| US6013290A (en) * | 1997-11-17 | 2000-01-11 | Weinstein; Robert E. | Assemblage of nutrient beverages and regimen for enhancing convenience, instruction, and compliance with exercise supplementation |
| US6051236A (en) * | 1998-11-12 | 2000-04-18 | Pacifichealth Laboratories, Inc. | Composition for optimizing muscle performance during exercise |
| DE69930464D1 (de) * | 1999-12-30 | 2006-05-11 | Kerry Group Services Ltd | Aufbaupräparat, das Kohlenhydrat- und Peptidmaterial enthält und sein Gebrauch als Energieergänzung nach oder während körperlicher Übung oder als metabolischer Nährstoff für die orale Verabreichung |
| WO2002047612A2 (en) * | 2000-10-27 | 2002-06-20 | Mannatech, Inc. | Dietary supplement compositions |
| US7740893B2 (en) * | 2001-04-02 | 2010-06-22 | Mott's Llp | Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise |
| US20030064134A1 (en) * | 2001-10-03 | 2003-04-03 | Eastman Outdoors | Kit, system and method for preparing home-made nutritional food items |
| US7288570B2 (en) * | 2002-12-20 | 2007-10-30 | Nutricia N.V. | Stimulation of in vivo production of proteins |
| JP2005070853A (ja) * | 2003-08-26 | 2005-03-17 | Md 21:Kk | ダイエットプログラムのメニュー作成方法及びそのシステム |
| US7205018B2 (en) * | 2004-10-07 | 2007-04-17 | Next Proteins, Inc. | Carbonated protein drink and method of making |
| EP1904070A4 (en) * | 2005-07-07 | 2009-09-02 | H3 Formulations Ltd | NUTRITIONAL SUPPLEMENT FOR IMPROVING SKELETAL MUSHROOMS, REDUCING MUSCLE PROTEIN DEGRADATION, DOWNGRADING MUSCLE CATABOLISM PATHS, AND REDUCING CATABOLISM OF MUSCLE CELLS |
| EP1973426A2 (en) * | 2005-11-03 | 2008-10-01 | Southwest Immunology Inc. | Compositions for preventing and reducing delayed onset muscle soreness |
| US20070243290A1 (en) * | 2006-04-18 | 2007-10-18 | Melody Thompson | Method of tailoring infant formulas to individual nutritional needs prior to use |
| WO2007133642A1 (en) * | 2006-05-11 | 2007-11-22 | Garcia Ramon D | Sport drink containing amino acids and carbohydrates |
| RU2306720C1 (ru) * | 2006-07-06 | 2007-09-27 | Энвер Саидович Токаев | Продукт "спортамин" для питания спортсменов |
| US20090169684A1 (en) * | 2007-12-29 | 2009-07-02 | Cresta Andrea K | Fitness and exercise enhancing tablet containing protein isolate |
| EP2098126A1 (en) * | 2008-03-03 | 2009-09-09 | Nestec S.A. | Carbohydrate Bar |
-
2009
- 2009-11-29 EP EP09177423.2A patent/EP2327316B1/en not_active Not-in-force
-
2010
- 2010-11-29 PH PH1/2012/500875A patent/PH12012500875A1/en unknown
- 2010-11-29 JP JP2012540457A patent/JP5810429B2/ja not_active Expired - Fee Related
- 2010-11-29 MX MX2012005646A patent/MX2012005646A/es active IP Right Grant
- 2010-11-29 CA CA2781764A patent/CA2781764A1/en not_active Abandoned
- 2010-11-29 US US13/511,854 patent/US20130203645A1/en not_active Abandoned
- 2010-11-29 NZ NZ600094A patent/NZ600094A/en not_active IP Right Cessation
- 2010-11-29 IN IN4085DEN2012 patent/IN2012DN04085A/en unknown
- 2010-11-29 AU AU2010323089A patent/AU2010323089B2/en not_active Ceased
- 2010-11-29 WO PCT/EP2010/068439 patent/WO2011064373A1/en not_active Ceased
- 2010-11-29 RU RU2012127126/13A patent/RU2503269C1/ru not_active IP Right Cessation
- 2010-11-29 CN CN201080053149.6A patent/CN102665445B/zh not_active Expired - Fee Related
- 2010-11-29 BR BR112012012811A patent/BR112012012811A2/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010323089A1 (en) | 2012-05-31 |
| PH12012500875A1 (en) | 2013-01-07 |
| BR112012012811A2 (pt) | 2015-09-15 |
| CN102665445B (zh) | 2015-03-25 |
| CA2781764A1 (en) | 2011-06-03 |
| AU2010323089B2 (en) | 2014-07-24 |
| US20130203645A1 (en) | 2013-08-08 |
| NZ600094A (en) | 2014-10-31 |
| RU2503269C1 (ru) | 2014-01-10 |
| WO2011064373A1 (en) | 2011-06-03 |
| MX2012005646A (es) | 2012-06-13 |
| HK1175664A1 (en) | 2013-07-12 |
| EP2327316A1 (en) | 2011-06-01 |
| IN2012DN04085A (cg-RX-API-DMAC7.html) | 2015-08-07 |
| EP2327316B1 (en) | 2016-11-16 |
| JP2013511970A (ja) | 2013-04-11 |
| CN102665445A (zh) | 2012-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5810429B2 (ja) | 筋タンパク質合成を強化する方法 | |
| Helms et al. | Evidence-based recommendations for natural bodybuilding contest preparation: nutrition and supplementation | |
| Williams | Dietary supplements and sports performance: amino acids | |
| Bishop et al. | The effects of carbohydrate supplementation on immune responses to a soccer-specific exercise protocol | |
| Wall et al. | Dietary protein considerations to support active aging | |
| Chen et al. | Arginine and antioxidant supplement on performance in elderly male cyclists: a randomized controlled trial | |
| Artioli et al. | Nutrition in combat sports | |
| Camera | Evaluating the effects of increased protein intake on muscle strength, hypertrophy and power adaptations with concurrent training: a narrative review | |
| Rudolf et al. | Sport nutrition: the role of macronutrients and minerals in endurance exercises | |
| Terasawa et al. | Effect of l-citrulline intake on intermittent short-time high-intensity exercise performance in male collegiate track athletes | |
| Tarnopolsky | Building muscle: nutrition to maximize bulk and strength adaptations to resistance exercise training | |
| Apong | Nutrition and dietary recommendations for bodybuilders | |
| Rietschier et al. | Sun-dried raisins are a cost-effective alternative to sports jelly beans in prolonged cycling | |
| AU2016202730A1 (en) | Method of enhancing muscle protein synthesis | |
| AU2014253534A1 (en) | Method of enhancing muscle protein synthesis | |
| Genton | Clinical Nutrition University: Calorie and macronutrient requirements for physical fitness | |
| Sharawy | The effects of A pre-and post-exercise Whey Protein Supplement on Protein Metabolism and muscular strength among elite wrestlers | |
| HK1175664B (en) | Method of enhancing muscle protein synthesis | |
| Guleria et al. | Role of nutrients and sports drinks on sports performance: A review | |
| Close et al. | Nutrition for Rugby | |
| Bird et al. | Supplementation Strategies for Strength and Power Athletes: Carbohydrate, Protein, and Amino Acid Ingestion. Nutrients 2024, 16, 1886 | |
| Yang et al. | Okara supplementation relieves fatigue and muscle damage that occur during exercise training | |
| Moura et al. | Nutrition Supplements in Sports | |
| Tamirci et al. | Energy Balance and Management in Sports and Exercise | |
| Meeusen et al. | Supplementation strategies for strength and power athletes: Carbohydrate, Protein, and Amino Acid Ingestion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130815 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130910 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131210 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140805 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141205 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20141205 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141209 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141218 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20141209 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20150304 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150421 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150717 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150818 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150826 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5810429 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |